| 000 | 01079 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250516165808.0 | ||
| 264 | 0 | _c20140402 | |
| 008 | 201404s 0 0 eng d | ||
| 022 | _a1349-7413 | ||
| 024 | 7 |
_a10.2177/jsci.36.209 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYasuda, Hisataka | |
| 245 | 0 | 0 |
_aAnti-RANKL antibody was approved for the treatment of osteoporosis in Japan. _h[electronic resource] |
| 260 |
_bNihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology _c2013 |
||
| 300 |
_a209-16 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
| 650 | 0 | 4 | _aDenosumab |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOsteoclasts _xdrug effects |
| 650 | 0 | 4 |
_aOsteoporosis _xdrug therapy |
| 650 | 0 | 4 |
_aRANK Ligand _ximmunology |
| 773 | 0 |
_tNihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology _gvol. 36 _gno. 4 _gp. 209-16 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2177/jsci.36.209 _zAvailable from publisher's website |
| 999 |
_c23050095 _d23050095 |
||